Abstract
We prospectively studied antinuclear antibodies induced by isoniazid in 109 patients with pulmonary tuberculosis. Ten of 50 patients (20.0%) with complete follow-up developed antinuclear antibodies after anti-tuberculous treatment. None developed symptoms of systemic lupus erythematosus. Female had a higher incidence to develop antinuclear antibodies than men (p＜0.01). Antinuclear antibodies in these patients were treated with various antituberculosis drugs, isoniazid was the only drug that can induce antinuclear antibodies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
